New linker structures applied in glycosite-specific antibody drug conjugates
FARIDOON FARIDOON(Chinese Academy of Sciences), Wei Huang(Chinese Academy of Sciences), Ken Qin(Chinese Academy of Sciences), Jinhua Dong(Shenyang Pharmaceutical University), Xiaobo Tian(Nanchang University), Bofeng Jiang(Chinese Academy of Sciences), Mingjie Li(Shenyang Pharmaceutical University), Wei Shi(Chinese Academy of Sciences), Dongliang Guan(Chinese Academy of Sciences), Yubo Tang(Sun Yat-sen University), Feng Tang(Chinese Academy of Sciences)
Cited by 14
Related Papers
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry
|Modern Pathology|2023|98
Sulfonium, an Underestimated Moiety for Structural Modification, Alters the Antibacterial Profile of Vancomycin Against Multidrug‐Resistant Bacteria
|Angewandte Chemie International Edition|2019|92
Selective N-glycan editing on living cell surfaces to probe glycoconjugate function
|Nature Chemical Biology|2020|64
Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant <i>Staphylococcus aureus</i> and Vancomycin-Resistant <i>Enterococci</i>
|Journal of Medicinal Chemistry|2017|59
Potentiation of Vancomycin: Creating Cooperative Membrane Lysis through a “Derivatization-for-Sensitization” Approach
|Journal of the American Chemical Society|2022|32